Revenue segments as reported by the company.

Premiums earned, net

Other income

Investment income, net

Direct Contracting revenue

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Net medical claims incurred

Salaries and benefits

General and administrative expenses

Premium deficiency reserve (benefit) expense

Depreciation and amortization

Other expense

Restructuring costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Clover Health Investments

Clover Health Investments Corp. provides healthcare insurance services. It uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outcomes and lower costs for patients. The company was founded on July 17, 2014 and is headquartered in Franklin, TN.

Earnings data Q3 2023

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

FRANKLIN, Tenn., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that it will host a virtual Clover Assistant Showcase on Thursday, October 12, 2023 at 12:00 p.m. Eastern Time. The event will feature informative product demonstrations, followed by a live Q&A session with Clover executives and key members of the Clover Assistant team.

Clover Health to Host Virtual Clover Assistant Showcase on October 12, 2023

Here is how Clover Health Investments, Corp. (CLOV) and Axcella Health Inc. (AXLA) have performed compared to their sector so far this year.

Are Medical Stocks Lagging Clover Health Investments (CLOV) This Year?

Clover Health (NASDAQ: CLOV) stock price has pulled back in the past few days as the recent uptrend eased. The shares were trading at $1.30 on Thursday, lower than this month's high of $1.63.

Clover Health stock price could jump by 54% if this happens

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Clover Health Investments, Corp. (CLOV) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

Clover Health Investments, Corp. (CLOV) Shows Fast-paced Momentum But Is Still a Bargain Stock

Clover Health beat analysts' estimates in Q2. The company also raised the lower end of its full-year insurance revenue guidance range.

Why Clover Health Stock Is Soaring Today

Clover Health Investments, Corp. (CLOV) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to loss of $0.22 per share a year ago.

Clover Health Investments, Corp. (CLOV) Reports Q2 Loss, Tops Revenue Estimates

Insurance revenue grew 17% compared to Q2'22, and second quarter Insurance MCR improved to 77.2% , bringing first half MCR to 81.9%

Clover Health Reports Strong Second Quarter 2023 Results; Highlights Improved Financial Performance and Guidance Ranges

FRANKLIN, Tenn., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that it has received formal notice from The Nasdaq Stock Market, LLC ("Nasdaq") stating that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1). As previously disclosed, the Company received a written notice from Nasdaq on April 20, 2023 notifying the Company that it had failed to meet the $1.00 per share minimum bid price requirement for continued inclusion on The Nasdaq Global Select Market.

Clover Health Regains Compliance with NASDAQ Minimum Bid Price Requirement

FRANKLIN, Tenn., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today announced its participation in the following investor conferences:

Clover Health to Present at Canaccord Genuity 43rd Annual Growth Conference and 2023 Wells Fargo Healthcare Conference

Retrospective data analysis covering seven thousand patients and over two thousand primary care providers finds clinicians using Clover Assistant identify and treat CKD Stage 3 earlier in its progression, changing the trajectory of illness. Results were the same even when restricting analysis to the same provider before and after their adoption of Clover Assistant. Retrospective data analysis covering seven thousand patients and over two thousand primary care providers finds clinicians using Clover Assistant identify and treat CKD Stage 3 earlier in its progression, changing the trajectory of illness. Results were the same even when restricting analysis to the same provider before and after their adoption of Clover Assistant.

Clinician Use of Clover Assistant is Associated with Significant Improvement in the Early Identification and Management of Chronic Kidney Disease

The healthcare insurer specializes in Medicare Advantage plans. The stock is likely no longer in danger of being delisted from the NASDAQ.

Why Shares of Clover Health Jumped This Week

CleanSpark

FuelCell Energy

Marathon Digital Holdings

Nikola

SoundHound AI Inc

Virgin Galactic

WeWork

It's been a tough year for those in the business of shorting stocks, as a feared recession hasn't arrived, which has allowed the beaten-down of Corporate America to survive, if perhaps not thrive. According to HFR, hedge funds have returned just 3% this year, which makes sense given the terrible results for managers who are shorting securities.

It's a dash for trash right now, and these lotto stocks have rocketed 86% on average

FRANKLIN, Tenn., July 11, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that it will report second quarter 2023 financial results after market close on Tuesday, August 8, 2023. On that day management will host a conference call and webcast at 5:00 p.m. Eastern Time to discuss the Company's business and financial results.

Clover Health to Report Second Quarter 2023 Financial Results on August 8, 2023

The health insurer is having trouble adding to its membership base. If its software succeeds in helping stakeholders to cut costs, that might change.

Clover Health Is Down 68% In 1 Year, But Wall Street Is Predicting It'll Rise by 70%. Should You Buy It?

Augmedix

Definitive Healthcare Corp

Zacks Medical Info Systems industry stocks like Definitive Healthcare (DH), Clover Health Investments (CLOV) and Augmedix (AUGX) are expected to gain from new normal trends.

3 Medical Info Systems Stocks to Consider From a Prospering Industry

Fast-paced Momentum Stock Clover Health Investments, Corp. (CLOV) Is Still Trading at a Bargain

FRANKLIN, Tenn., June 22, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that the Company has reached an agreement in principle to resolve seven derivative lawsuits pending in Delaware, New York, and Tennessee courts (collectively, the “derivative lawsuits”). The proposed derivative settlement contains no admission of liability or wrongdoing by any of the defendants and is subject to definitive documentation and final court approval. Along with the settlement of the securities class action described in the Company's April 24, 2023 press release, the Company has now reached settlements for all of the outstanding civil litigation that was filed following its de-SPAC transaction.

Clover Health Announces Agreement to Settle Derivative Litigation, Resolving All Remaining Civil Litigation Relating to its de-SPAC Transaction

Faraday Future Intelligent Electric

With the stock market surging, investors are looking at more speculative opportunities for outsized gains. But investors should be careful with low-priced equities, and in particular these three overvalued penny stocks.

Time's Ticking: Dump These 3 Overvalued Penny Stocks

AMC Entertainment

Blue Apron

Carvana

GameStop

Plug Power

Lordstown Motors

You may think a call to “sell meme stocks now” is an overreaction. After all, a fair number of meme names have performed well lately, suggesting a “renaissance” of sorts for this investing trend.

The Meme Stock Frenzy is Over: Sell These Seven Now

FuboTV

MannKind

Mullen Automotive

Rite Aid

Exela Technologies

While there are plenty of bargains to buy among penny stocks, there are also a good amount of overvalued penny stocks to sell. While significantly lower-priced now than they were at their respective high water-marks, many of these stocks are hardly bargains, trading at valuations unsustainable relative to their current operating performance.

7 Overvalued Penny Stocks to Sell Before June 2023

Here is how Clover Health Investments, Corp. (CLOV) and Pyxis Oncology, Inc. (PYXS) have performed compared to their sector so far this year.

Is Clover Health Investments (CLOV) Stock Outpacing Its Medical Peers This Year?

Pieris Pharma

Porch Group

Penny stocks under $1 to watch right now. The post Best Penny Stocks to Buy?

Best Penny Stocks to Buy? 3 Under $1 To Watch Before Next Week

Clover Health Investments, Corp. (CLOV) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to loss of $0.19 per share a year ago.

Clover Health Investments, Corp. (CLOV) Reports Q1 Loss, Tops Revenue Estimates

Clover Health Investments, Corp. (NASDAQ:CLOV ) Q1 2023 Results Conference Call May 9, 2023 5:00 PM ET Company Participants Ryan Schmidt - IR Andrew Toy - CEO Scott Leffler - CFO Conference Call Participants Jonathan Yong - Credit Suisse Operator Ladies and gentlemen, good afternoon, and welcome to the Clover Health First Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, today's call is being recorded.

Clover Health Investments, Corp. (CLOV) Q1 2023 Earnings Call Transcript

Insurance revenue grew by 14% over Q1'22 Insurance and Non-Insurance MCR improved to 86.6% and 96.1% , respectively Improved 2023 guidance includes Insurance MCR of 87% - 89% , Insurance revenue of $1.18 billion - $1.23 billion , and Adjusted EBITDA of ($125) million - ($175) million FRANKLIN, Tenn., May 09, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) ("Clover," "Clover Health" or the "Company"), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today reported financial results for the first quarter 2023.

News for Clover Health Investments Stock (CLOV)